Record Information |
---|
Version | 2.0 |
---|
Created at | 2023-09-06 20:02:04 UTC |
---|
Updated at | 2024-09-03 04:16:57 UTC |
---|
NP-MRD ID | NP0331793 |
---|
Natural Product DOI | https://doi.org/10.57994/0871 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Acetylsalisylic acid |
---|
Description | Aspirin, also known as acetylsalicylate or ASA, belongs to the class of organic compounds known as acylsalicylic acids. These are o-acylated derivatives of salicylic acid. Aspirin is an extremely weak basic (essentially neutral) compound (based on its pKa). In humans, aspirin is involved in acetaminophen action pathway. Outside of the human body, Aspirin has been detected, but not quantified in, herbs and spices. This could make aspirin a potential biomarker for the consumption of these foods. Aspirin is a potentially toxic compound. Acetylsalisylic acid was first documented in 2000 (PMID: 11203441). It was isolated from meadowsweet (Filipendula ulmaria, formerly classified as Spiraea ulmaria) by German researchers in 1839 (PMID: 11402787) (PMID: 11597554) (PMID: 11733186) (PMID: 12852484) (PMID: 14753751) (PMID: 15542410). |
---|
Structure | InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12) |
---|
Synonyms | Value | Source |
---|
2-(ACETYLOXY)benzoIC ACID | ChEBI | 2-Acetoxybenzenecarboxylic acid | ChEBI | 2-Acetoxybenzoic acid | ChEBI | Acetylsalicylate | ChEBI | Acetylsalicylsaeure | ChEBI | Acide 2-(acetyloxy)benzoique | ChEBI | Acide acetylsalicylique | ChEBI | Acido acetilsalicilico | ChEBI | Acidum acetylsalicylicum | ChEBI | ASA | ChEBI | Azetylsalizylsaeure | ChEBI | Easprin | ChEBI | O-Acetoxybenzoic acid | ChEBI | O-Acetylsalicylic acid | ChEBI | O-Carboxyphenyl acetate | ChEBI | Salicylic acid acetate | ChEBI | Acetylsalicylic acid | Kegg | Aspalon | Kegg | Durlaza | Kegg | 2-(ACETYLOXY)benzoate | Generator | 2-Acetoxybenzenecarboxylate | Generator | 2-Acetoxybenzoate | Generator | O-Acetoxybenzoate | Generator | O-Acetylsalicylate | Generator | O-Carboxyphenyl acetic acid | Generator | Salicylate acetate | Generator | Salicylic acid acetic acid | Generator | 2-Carboxyphenyl acetate | HMDB | Acenterine | HMDB | Acetard | HMDB | Aceticyl | HMDB | Acetol | HMDB | Acetonyl | HMDB | Acetophen | HMDB | Acetosal | HMDB | Acetosalin | HMDB | Acetylin | HMDB | Acetyonyl | HMDB | Acetysal | HMDB | Acetysalicylic acid | HMDB | Acylpyrin | HMDB | Asatard | HMDB | Aspergum | HMDB | Aspirdrops | HMDB | Benaspir | HMDB | Bialpirinia | HMDB | Bufferin | HMDB | Caprin | HMDB | Cardioaspirina | HMDB | Ecolen | HMDB | Ecotrin | HMDB | Empirin | HMDB | Endosprin | HMDB | Endydol | HMDB | O-(Acetyloxy)benzoate | HMDB | O-(Acetyloxy)benzoic acid | HMDB | Persistin | HMDB | Pharmacin | HMDB | Polopiryna | HMDB | Premaspin | HMDB | Rheumintabletten | HMDB | Rhodine | HMDB | Salcetogen | HMDB | Saletin | HMDB | Salospir | HMDB | Solprin | HMDB | Solprin acid | HMDB | Solpyron | HMDB | Tasprin | HMDB | Temperal | HMDB | Toldex | HMDB | Triaminicin | HMDB | Magnecyl | HMDB | Polopirin | HMDB | Solupsan | HMDB | Zorprin | HMDB | Dispril | HMDB | Aloxiprimum | HMDB | Colfarit | HMDB | Micristin | HMDB | Acid, acetylsalicylic | HMDB |
|
---|
Chemical Formula | C9H8O4 |
---|
Average Mass | 180.1574 Da |
---|
Monoisotopic Mass | 180.04226 Da |
---|
IUPAC Name | 2-(acetyloxy)benzoic acid |
---|
Traditional Name | aspirin |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(=O)OC1=CC=CC=C1C(O)=O |
---|
InChI Identifier | InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12) |
---|
InChI Key | BSYNRYMUTXBXSQ-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2023-09-06 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2023-09-06 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50.18 MHz, CDCl3, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as acylsalicylic acids. These are o-acylated derivatives of salicylic acid. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzoic acids and derivatives |
---|
Direct Parent | Acylsalicylic acids |
---|
Alternative Parents | |
---|
Substituents | - Acylsalicylic acid
- Phenol ester
- Benzoic acid
- Phenoxy compound
- Benzoyl
- Dicarboxylic acid or derivatives
- Carboxylic acid ester
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Epelde F, Garca-Castrillo Riesgo L, Loma-Osorio A, Verdier J, Recuerda Martnez E: [The use of acetylsalicylic acid in patients with ischemic cardiomyopathy cared for in Spanish emergency services (results of the EVICURE Study). Evaluacion del Manejo de la cardiopatia isquemica en los Servicios de Urgencias Hospitalarios of the Sociedad Espanola de Medicina de Urgencias y Emergencias (SEMES)]. Med Clin (Barc). 2000 Oct 14;115(12):455-7. doi: 10.1016/s0025-7753(00)71590-9. [PubMed:11203441 ]
- Sexton RC Jr: Aspirin in cardiovascular disease. Tenn Med. 2001 Jun;94(6):208-10. [PubMed:11402787 ]
- Schroder A, Levin RM, Kogan BA, Longhurst PA: Aspirin treatment improves bladder function after outlet obstruction in rabbits. Urology. 2001 Oct;58(4):608-13. doi: 10.1016/s0090-4295(01)01291-2. [PubMed:11597554 ]
- Bazzi MD, Rabbani N, Duhaiman AS: Inhibition of camel lens zeta-crystallin by aspirin and aspirin-like analgesics. Int J Biochem Cell Biol. 2002 Jan;34(1):70-7. doi: 10.1016/s1357-2725(01)00099-1. [PubMed:11733186 ]
- Streck RD, Kumpf SW, Ozolins TR, Stedman DB: Rat embryos express transcripts for cyclooxygenase-1 and carbonic anhydrase-4, but not for cyclooxygenase-2, during organogenesis. Birth Defects Res B Dev Reprod Toxicol. 2003 Feb;68(1):57-69. doi: 10.1002/bdrb.10006. [PubMed:12852484 ]
- Kutuk O, Basaga H: Aspirin prevents apoptosis and NF-kappaB activation induced by H2O2 in hela cells. Free Radic Res. 2003 Dec;37(12):1267-76. doi: 10.1080/10715760310001616005. [PubMed:14753751 ]
- Witte KK, Clark AL: The effect of aspirin on the ventilatory response to exercise in chronic heart failure. Eur J Heart Fail. 2004 Oct;6(6):745-8. doi: 10.1016/j.ejheart.2003.11.008. [PubMed:15542410 ]
- Huang ZW, Luo Y, Wu Z, Tao Z, Jones RO, Zhao HB: Paradoxical enhancement of active cochlear mechanics in long-term administration of salicylate. J Neurophysiol. 2005 Apr;93(4):2053-61. doi: 10.1152/jn.00959.2004. Epub 2004 Dec 8. [PubMed:15590729 ]
- Watson HG, Chee YL: Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism. Blood Rev. 2008 Mar;22(2):107-16. doi: 10.1016/j.blre.2007.11.001. Epub 2008 Jan 15. [PubMed:18226435 ]
|
---|